$HR
Healthcare Realty Trust Inc Stock $hr

$hr Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000136060415000024 Filed on May 06, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$98.52M	$91.30M
YoY Change	7.9%	18.79%
Cost Of Revenue	$34.30M	$32.80M
YoY Change	4.57%	11.56%
Gross Profit	$62.20M	$57.70M
YoY Change	7.8%	13.58%
Gross Profit Margin	63.13%	63.2%
Selling, General & Admin	$6.500M	$6.000M
YoY Change	8.33%	-7.69%
% of Gross Profit	10.45%	10.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$30.20M	$28.00M
YoY Change	7.86%	53.85%
% of Gross Profit	48.55%	48.53%
Operating Expenses	$35.60M	$32.50M
YoY Change	9.54%	7.26%
Operating Profit	$23.30M	$19.50M
YoY Change	19.48%	56.57%
Interest Expense	-$18.20M	-$17.80M
YoY Change	2.25%	-8.72%
% of Operating Profit	-78.13%	-91.29%
Other Income/Expense, Net	$15.00K	$26.00K
YoY Change	-42.31%	225.0%
Pretax Income	$5.000M	$7.500M
YoY Change	-33.33%	733.33%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$6.804M	$5.292M
YoY Change	28.57%	291.71%
Net Earnings / Revenue	6.91%	5.8%
Basic Earnings Per Share	$0.05	$0.04
Diluted Earnings Per Share	$0.05	$0.04
COMMON SHARES
Basic Shares Outstanding	125.2M shares	118.6M shares
Diluted Shares Outstanding	127.1M shares	119.9M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.40M	$10.20M
YoY Change	1.96%	-89.17%
Cash & Equivalents	$13.52M	$27.36M
Short-Term Investments
Other Short-Term Assets	$26.00M	$9.000M
YoY Change	188.89%	28.57%
Inventory
Prepaid Expenses
Receivables	$16.00M	$21.00M
Other Receivables	$68.00M	$53.00M
Total Short-Term Assets	$10.40M	$10.20M
YoY Change	1.96%	-89.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.574B	$2.454B
YoY Change	4.88%	10.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.20M	$10.20M
YoY Change	39.22%	-54.26%
Total Long-Term Assets	$3.039B	$2.725B
YoY Change	11.51%	9.18%
TOTAL ASSETS
Total Short-Term Assets	$10.40M	$10.20M
Total Long-Term Assets	$3.039B	$2.725B
Total Assets	$3.049B	$2.735B
YoY Change	11.47%	5.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.10M	$50.70M
YoY Change	-1.18%	11.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$50.10M	$50.70M
YoY Change	-1.18%	11.43%
LONG-TERM LIABILITIES
Long-Term Debt	$1.445B	$1.388B
YoY Change	4.06%	-1.9%
Other Long-Term Liabilities	$64.60M	$60.40M
YoY Change	6.95%	4.14%
Total Long-Term Liabilities	$1.509B	$1.449B
YoY Change	4.18%	-1.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.10M	$50.70M
Total Long-Term Liabilities	$1.509B	$1.449B
Total Liabilities	$1.598B	$1.360B
YoY Change	17.47%	9.31%
SHAREHOLDERS EQUITY
Retained Earnings		-$770.9M
YoY Change		15.99%
Common Stock	$2.284B	$2.130B
YoY Change	7.22%	6.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.418B	$1.359B
YoY Change
Total Liabilities & Shareholders Equity	$3.049B	$2.735B
YoY Change	11.47%	5.6%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	$6.804M	$5.292M
YoY Change	28.57%	291.71%
Depreciation, Depletion And Amortization	$30.20M	$28.00M
YoY Change	7.86%	53.85%
Cash From Operating Activities	$37.20M	$33.45M
YoY Change	11.2%	19.73%
INVESTING ACTIVITIES
Capital Expenditures	-$48.30M	-$15.90M
YoY Change	203.77%	-36.4%
Acquisitions
YoY Change
Other Investing Activities	-$4.300M	-$600.0K
YoY Change	616.67%	-97.41%
Cash From Investing Activities	-$42.15M	-$5.966M
YoY Change	606.42%	-93.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.292M	$572.0K
YoY Change	125.87%	-100.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$8.054M	-$18.21M
YoY Change	-144.24%	-110.76%
NET CHANGE
Cash From Operating Activities	$37.20M	$33.45M
Cash From Investing Activities	-$42.15M	-$5.966M
Cash From Financing Activities	$8.054M	-$18.21M
Net Change In Cash	$3.104M	$9.278M
YoY Change	-66.54%	-91.16%
FREE CASH FLOW
Cash From Operating Activities	$37.20M	$33.45M
Capital Expenditures	-$48.30M	-$15.90M
Free Cash Flow	$85.50M	$49.35M
YoY Change	73.25%	-6.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE TRUST OF AMERICA, INC.
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001360604
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	125199971	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q1	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	976000	USD
CY2015Q1	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	1357000	USD
CY2014Q1	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	34111000	USD
CY2015Q1	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	35788000	USD
CY2014Q4	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	5620000	USD
CY2015Q1	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	5993000	USD
CY2014Q4	hta	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	18045000	USD
CY2015Q1	hta	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	18457000	USD
CY2014Q4	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	12425000	USD
CY2015Q1	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	12464000	USD
CY2014	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P17Y1M6D
CY2015Q1	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P16Y10M17D
CY2015Q1	hta	Inceptionto Date Acquisition Purchase Price InceptiontoDateAcquisitionPurchasePrice	3400000000	USD
CY2014Q1	hta	Increase Decreasein Restricted Cash Escrow Depositsand Other IncreaseDecreaseinRestrictedCashEscrowDepositsandOther	396000	USD
CY2014Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	16468000	USD
CY2015Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	16435000	USD
CY2014Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	836044000	USD
CY2015Q1	hta	Increase Decreasein Restricted Cash Escrow Depositsand Other IncreaseDecreaseinRestrictedCashEscrowDepositsandOther	321000	USD
CY2014Q1	hta	Increase Decreasein Security Deposits Prepaid Rentand Other Liabilities IncreaseDecreaseinSecurityDepositsPrepaidRentandOtherLiabilities	-2517000	USD
CY2015Q1	hta	Increase Decreasein Security Deposits Prepaid Rentand Other Liabilities IncreaseDecreaseinSecurityDepositsPrepaidRentandOtherLiabilities	4290000	USD
CY2014Q1	hta	Interest Expense Derivative Financial Instruments InterestExpenseDerivativeFinancialInstruments	1345000	USD
CY2015Q1	hta	Interest Expense Derivative Financial Instruments InterestExpenseDerivativeFinancialInstruments	555000	USD
CY2014Q1	hta	Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments	2186000	USD
CY2015Q1	hta	Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments	2565000	USD
CY2014Q1	hta	Paymentof Earnout PaymentofEarnout	375000	USD
CY2015Q1	hta	Paymentof Earnout PaymentofEarnout	0	USD
CY2014Q1	hta	Paymentsfor Proceedsfrom Security Deposits PaymentsforProceedsfromSecurityDeposits	-247000	USD
CY2015Q1	hta	Paymentsfor Proceedsfrom Security Deposits PaymentsforProceedsfromSecurityDeposits	17000	USD
CY2014Q4	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	144106000	USD
CY2015Q1	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	143808000	USD
CY2014Q4	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	32687000	USD
CY2015Q1	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	38947000	USD
CY2014Q4	hta	Variable Interest Entity Loans Receivable VariableInterestEntityLoansReceivable	80500000	USD
CY2015Q1	hta	Variable Interest Entity Loans Receivable VariableInterestEntityLoansReceivable	80500000	USD
CY2014Q4	hta	Variable Interest Entity Numberof Entities VariableInterestEntityNumberofEntities	5	entity
CY2015Q1	hta	Variable Interest Entity Numberof Entities VariableInterestEntityNumberofEntities	5	entity
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	101042000	USD
CY2015Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	84823000	USD
CY2015Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	865549000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2281932000	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2282553000	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1388000	USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1914000	USD
CY2014Q1	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	874000	USD
CY2015Q1	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	986000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	966000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	842000	USD
CY2014Q4	us-gaap	Assets Assets	3041650000	USD
CY2015Q1	us-gaap	Assets Assets	3049086000	USD
CY2014Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2272000	USD
CY2015Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1464000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18081000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27359000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10413000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13517000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9278000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3104000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	482457000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	296765000	USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	1251000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	1252000	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	71806000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	75224000	USD
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1412873000	USD
CY2015Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1458913000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	412000	USD
CY2015Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	315000	USD
CY2014Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17281000	USD
CY2015Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17614000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	16929000	USD
CY2015Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	16393000	USD
CY2014Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	56433000	USD
CY2015Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	59102000	USD
CY2014Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	34942000	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36595000	USD
CY2014Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	USD
CY2015Q1	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	194000	USD
CY2014Q4	us-gaap	Derivative Assets DerivativeAssets	1714000	USD
CY2015Q1	us-gaap	Derivative Assets DerivativeAssets	0	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1714000	USD
CY2015Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	194000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2888000	USD
CY2015Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3378000	USD
CY2014Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2888000	USD
CY2015Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	3184000	USD
CY2014Q4	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	0	USD
CY2015Q1	us-gaap	Derivative Liability Collateral Right To Reclaim Cash Offset DerivativeLiabilityCollateralRightToReclaimCashOffset	194000	USD
CY2014Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	29589000	USD
CY2015Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	30697000	USD
CY2014Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	34459000	USD
CY2015Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	36873000	USD
CY2014Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	34148000	USD
CY2015Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	36309000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	182149000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	193723000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	478914000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	288734000	USD
CY2014	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P15Y2M12D
CY2015Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P15Y3M
CY2014Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-841000	USD
CY2015Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-2010000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6299000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6575000	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	58000	USD
CY2015Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	99000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4168000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13172000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	1739000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	723000	USD
CY2014Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	11904000	USD
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	13804000	USD
CY2014Q1	us-gaap	Interest Income Operating InterestIncomeOperating	852000	USD
CY2015Q1	us-gaap	Interest Income Operating InterestIncomeOperating	68000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	8235000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	13238000	USD
CY2014Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2665777000	USD
CY2015Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2699979000	USD
CY2014Q4	us-gaap	Land Land	287755000	USD
CY2015Q1	us-gaap	Land Land	288503000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	1561503000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	1598210000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3041650000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3049086000	USD
CY2015Q1	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.985
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	1412461000	USD
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	1458598000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	773633000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	429680000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	14803000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	116977000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	69985000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	53835000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	29282000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	28823000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-18205000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8054000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5966000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42145000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	33449000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37195000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	5292000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	6804000	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	142000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	138000	USD
CY2014Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	5390000	USD
CY2015Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	6909000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	26000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	19498000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	23296000	USD
CY2014Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	90452000	USD
CY2015Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	98452000	USD
CY2014Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	419288000	USD
CY2015Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	420094000	USD
CY2014Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	43488000	USD
CY2015Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	45231000	USD
CY2014Q4	us-gaap	Other Receivables OtherReceivables	10639000	USD
CY2015Q1	us-gaap	Other Receivables OtherReceivables	7989000	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	572000	USD
CY2015Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1292000	USD
CY2014Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1077000	USD
CY2015Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	31000	USD
CY2014Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	34052000	USD
CY2015Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	36275000	USD
CY2014Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	475000	USD
CY2015Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	371000	USD
CY2014Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5570000	USD
CY2015Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	6524000	USD
CY2014Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2015Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	35300000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	24642000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	26081000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	65000000	USD
CY2014Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30000000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	5434000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	6942000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	99000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	146000	USD
CY2015Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	82000000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	20799000	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	21120000	USD
CY2014Q1	us-gaap	Revenues Revenues	91304000	USD
CY2015Q1	us-gaap	Revenues Revenues	98520000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1388000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1914000	USD
CY2014Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	572000	USD
CY2015Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1292000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1447139000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	1418256000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127105000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118644000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125175000	shares
CY2014Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	549976000	USD
CY2015Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	583166000	USD
CY2014Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	3372820000	USD
CY2015Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	3408576000	USD
CY2014Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2822844000	USD
CY2015Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	2825410000	USD
CY2014Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3726000	USD
CY2015Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	3797000	USD
CY2014Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10000000	USD
CY2015Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	81000000	USD
CY2014Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1901000	USD
CY2015Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	19960000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1399749000	USD
CY2014Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1371496000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1476421000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1447079000	USD
CY2014Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5
CY2014Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	80500000	USD
CY2015Q1	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	80500000	USD
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1268000	shares
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1930000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	119912000	shares
CY2015Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HTA, a Maryland corporation, and </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, a Delaware limited partnership, were incorporated or formed, as applicable, on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 20, 2006</font><font style="font-family:inherit;font-size:10pt;">. HTA operates as a REIT and is the general partner of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, which is the operating partnership. As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, HTA owned a </font><font style="font-family:inherit;font-size:10pt;">98.5%</font><font style="font-family:inherit;font-size:10pt;"> partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">. As the sole general partner of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, HTA has the full, exclusive and complete responsibility for </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;"> and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">. As a result, HTA does not conduct business itself, other than acting as the sole general partner of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, issuing public equity from time to time and guaranteeing certain debts of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;"> conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the United States (“U.S.”) based on gross leaseable area (“GLA”). We are primarily focused on acquiring, owning and operating high quality MOBs that are predominantly located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. In addition, we have strong industry relationships, a stable and diversified tenant mix and an extensive and active acquisition network. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) seek internal growth through proactive asset management, leasing and property management oversight, (ii) target mid-sized acquisitions of MOBs in markets with dominant healthcare systems, and with attractive demographics that complement our existing portfolio, and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT. </font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We invest primarily in high quality MOBs in our target markets, and have acquired MOBs and other facilities that serve the healthcare industry with an aggregate purchase price of </font><font style="font-family:inherit;font-size:10pt;">$3.4 billion</font><font style="font-family:inherit;font-size:10pt;"> through </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective December 15, 2014, HTA completed a reverse stock split (the “Reverse Stock Split”) of its common stock. As a result of the Reverse Stock Split, every </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> issued and outstanding shares of common stock were converted into </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share of common stock. HTA’s par value and shares authorized remained unchanged. Concurrently with the Reverse Stock Split, </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;"> effected a corresponding Reverse Stock Split of its outstanding units of limited partnership interests. The weighted average number of shares/units and per share/unit amounts for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2014</font><font style="font-family:inherit;font-size:10pt;"> have been adjusted retroactively to reflect the Reverse Stock Split.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.</font></div></div>

Files In Submission

Name	View Source	Status
0001360604-15-000024-index-headers.html	Edgar Link	pending
0001360604-15-000024-index.html	Edgar Link	pending
0001360604-15-000024.txt	Edgar Link	pending
0001360604-15-000024-xbrl.zip	Edgar Link	pending
a2015331ex311.htm	Edgar Link	pending
a2015331ex312.htm	Edgar Link	pending
a2015331ex313.htm	Edgar Link	pending
a2015331ex314.htm	Edgar Link	pending
a2015331ex321.htm	Edgar Link	pending
a2015331ex322.htm	Edgar Link	pending
a2015331ex323.htm	Edgar Link	pending
a2015331ex324.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hta-20150331.xml	Edgar Link	completed
hta-20150331.xsd	Edgar Link	pending
hta-20150331_cal.xml	Edgar Link	unprocessable
hta-20150331_def.xml	Edgar Link	unprocessable
hta-20150331_lab.xml	Edgar Link	unprocessable
hta-20150331_pre.xml	Edgar Link	unprocessable
hta201533110-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HR
Healthcare Realty Trust Inc Stock $hr

2015 Q1 Form 10-Q Financial Statement

#000136060415000024 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR Healthcare Realty Trust Inc Stock $hr

2015 Q1 Form 10-Q Financial Statement

#000136060415000024 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR
Healthcare Realty Trust Inc Stock $hr